LONDON, December 14 /PRNewswire/ - The Benefits of Anastrozole (Arimidex(R)) Over Tamoxifen at Preventing Breast Cancer Recurrence Improve Over Time - Up to Four Years After Treatment Ends New data from ATAC(x), one of the world s largest and longest-running studies in postmenopausal women with hormone receptor positive (HR+), early breast cance
Grandmother of six, Rosie Gamp from Edgeware, London, cheated death by 21 years after her husband found a successful cancer drug trial for Armidex. She died age 90, but not from cancer.
Blood Hormone Levels Predict Anastrozole Efficacy in Post-Menopause miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Blood hormone levels identify which post-menopausal women will benefit most from a medication to prevent breast cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
<p>Research led by Queen Mary University of London’s Wolfson Institute of Population Health has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer.</p>